Clinical · Advanced Genomics
NGS · 150–180X Coverage

Whole Exome Sequencing

Sequence All 23,000 Protein-Coding Genes. End the Diagnostic Odyssey.

The exome is just 1–2% of your genome — yet it contains 85% of all known disease-causing mutations. Whole Exome Sequencing (WES) sequences all ~21,000 protein-coding genes at 150–180X depth using Illumina iScan technology, identifying the genetic cause of complex, rare, and undiagnosed conditions that have resisted every other test. For families who have been searching for answers for years, WES is often the final, definitive answer.

5.0 (Verified clinical test) NABL & CAP lab
Sample type
Blood + Saliva
Turnaround
31 days
Genes covered
~21,000
Coverage depth
150–180X

WES at a glance
~21,000
Protein-coding genes analyzed
85%
Of known disease mutations are in the exome
98%+
Exon coverage at 150–180X depth
95.9%
Sensitivity for variant detection

What you'll discover

Rare disease diagnosis

Identify disease-causing variants for rare, complex, and undiagnosed genetic conditions that other tests missed

End diagnostic odyssey

Neurodevelopmental disorders

Genetic basis of autism, global developmental delay, intellectual disability, and epilepsy

Neurogenetic causes

SNV + CNV detection

Both single nucleotide variants and copy number variations identified in a single comprehensive test

Dual variant types

De novo vs inherited variants

Distinguish between new spontaneous mutations and inherited variants — critical for recurrence risk counseling

Inheritance analysis

Precision medicine guidance

Specific gene variants inform targeted therapies, personalized treatment plans, and preventive strategies

Treatment guidance

Family risk assessment

Understand hereditary patterns and recurrence risks for siblings and future children

Family planning

How it works
1

Pre-test counseling (recommended)

Speak with our Genomic Expert before ordering to confirm WES is the right test for your clinical situation, and understand what to expect from results.

2

Order with referral confirmation

Confirm you have a doctor's referral. Your home collection kit ships within 24 hours — EDTA blood tube and saliva swab included.

3

Blood + Saliva sample collection

Collect both samples at home using the kit. 3–4ml EDTA blood + saliva swab. Return with prepaid courier label provided.

4

Exome capture + NGS sequencing

Exonic regions are captured and sequenced at 150–180X depth on Illumina iScan in our NABL & CAP accredited lab. All ~21,000 protein-coding genes analyzed.

5

Bioinformatics + ACMG classification

Variants classified as Pathogenic, Likely Pathogenic, VUS, or Benign per ACMG and ClinVar guidelines. Primary, incidental, and carrier findings all reported.

6

Clinical report + Genomic Expert consultation

Comprehensive WES report in 31 days. Detailed post-result consultation with our Genomic Expert to review findings and coordinate specialist referral.


Sample report preview

Your Whole Exome Sequencing Report

A snapshot of your comprehensive WES clinical report

Genes Analyzed
~21,000
Protein-coding + mitochondrial
Pathogenic Variants
0
No disease-causing variants found
Coverage Depth
165X
Average across all exons
Exon Coverage
98.4%
At minimum 10X depth
ACMG variant classification
Primary + incidental findings
SNV + CNV report
Carrier status findings
De novo vs inherited analysis
Clinician-ready PDF report

Frequently asked questions
Who should consider Whole Exome Sequencing?
WES is recommended for patients with unexplained symptoms, developmental delays, intellectual disabilities, neurodevelopmental disorders, or rare conditions that have remained undiagnosed despite extensive testing. It is especially valuable when targeted panel tests have been negative, when there is a "diagnostic odyssey" of multiple inconclusive tests, and when doctors need a molecular diagnosis to guide treatment or family planning decisions.
What is the difference between WES and Whole Genome Sequencing (WGS)?
WES sequences only the protein-coding regions (exons) — about 1–2% of the genome containing ~21,000 genes and 85% of known disease mutations. WGS sequences the entire genome including non-coding regions. WES is more affordable while covering the most clinically relevant regions. WGS is preferred when non-coding or structural variants are suspected, or when WES has been non-diagnostic.
Why do I need a doctor's referral?
WES generates complex clinical findings that require medical context to interpret correctly. A doctor's referral ensures the test is ordered for the right clinical indication, and that results are interpreted alongside the patient's phenotype and medical history. Our Genomic Expert will also provide post-result consultation to review all findings with you and coordinate appropriate follow-up care.
What are incidental findings?
Incidental findings are results unrelated to the original reason for testing. WES may identify variants linked to conditions such as hereditary cancer risk (BRCA, Lynch syndrome) or cardiac conditions, even if you were tested for a different reason. Per ACMG guidelines, we report actionable incidental findings. You will be informed before testing about this possibility and can discuss your preferences with our Genomic Expert.
Is my data safe and private?
Yes. All WES data is protected under ISO 27001, HIPAA, and GDPR standards. Your genetic data is never shared with insurance companies, employers, pharmaceutical companies, or any third party. You retain complete ownership and control of your information at all times.
MyGenoRoot AI Assistant
Ask anything about our DNA tests
Hi! I can answer your questions about MyGenoRoot's DNA tests — pricing, what's included, how testing works, and more. What would you like to know?
🔬 Clinical Genomics · Advanced
₹26,000 ₹35,000
You save ₹9,000 — 26% off launch price
  • All ~21,000 protein-coding genes sequenced
  • 150–180X coverage depth — high accuracy
  • SNV + CNV detection in single test
  • ACMG-guideline variant classification
  • NABL & CAP accredited lab
  • Post-result Genomic Expert consultation
Do you have a doctor's referral?
Yes, I do
No, I don't
No problem! After payment, we'll schedule a pre-test consultation with our Genomic Expert to guide you before sample collection begins.
Quantity
1
Secure checkout · SSL encrypted
Free pan-India shipping
Results in 31 days
Data never shared with insurers
NABL & CAP accredited
Genomic Expert Consultation — Included
After payment, you'll receive an appointment slot. If no referral, a pre-test consultation is scheduled first. Post-result consultation included for all.
Appointment booking link sent via email after order confirmation.
NABL & CAP

Accredited lab

~21,000 Genes

Complete exome coverage

150–180X Depth

High-accuracy sequencing

ISO 27001

Data security

100% Private

GDPR compliant

Related tests
People also explore

Complement or upgrade your genomic analysis

Complementary
Chromosomal MicroArray

CMA detects chromosomal deletions and duplications that WES may miss. Often ordered together for the most comprehensive chromosomal + gene analysis.

₹15,000
Most comprehensive
Upgrade
Whole Genome Sequencing

When WES is inconclusive, WGS sequences all 3 billion base pairs including non-coding regions — the most comprehensive genetic test available.

₹89,000
Targeted
BRCA 1 & 2 Sequencing

If WES reveals or suspects BRCA variants, targeted BRCA full gene sequencing provides detailed confirmation with clinical classification per ACMG guidelines.

₹15,000

Shipping Details

Where should we deliver your Beta-Thalassemia Screening kit?

Recipient name is required
Enter a valid 10-digit phone number
Address is required
City is required
Select your state
Enter a valid 6-digit pincode